Progression of striatal and extrastriatal degeneration in multiple system atrophy: A longitudinal diffusion-weighted MR study

Movement Disorders

Volumn 26, Issue 7, 2011, Pages 1303-1309

  Pellecchia, Maria Teresa ^a   Barone, Paolo ^a,b   Vicidomini, Caterina ^c   Mollica, Carmine ^c,d   Salvatore, Elena ^a   Ianniciello, Marta ^a   Liuzzi, Raffaele ^c   Longo, Katia ^a,b   Picillo, Marina ^a   De Michele, Giuseppe ^a   Filla, Alessandro ^a   Brunetti, Arturo ^a,c   Salvatore, Marco ^a,c   Pappatà, Sabina ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Neurological Institute for Diagnosis and Care Hermitage Capodimonte   (Italy)

^c CNR   (Italy)

^d IRCCS SDN   (Italy)

Author keywords

Diffusion weighted imaging; Longitudinal study; Multiple system atrophy

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CORPUS STRIATUM; CORRELATION ANALYSIS; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; FRONTAL LOBE; HUMAN; LONGITUDINAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NERVE DEGENERATION; PONS; PRIORITY JOURNAL; PUTAMEN; SCORING SYSTEM; SHY DRAGER SYNDROME; THALAMUS; UNIFIED MULTIPLE SYSTEM ATROPHY RATING SCALE; UNIFIED PARKINSON DISEASE RATING SCALE; WHITE MATTER;

AGED; CORPUS STRIATUM; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NERVE DEGENERATION;

EID: 79959351063     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23601     Document Type: Article

References (28)

1. Wenning GK, Ben-Shlomo Y, Magalhaes M, Daniel SE, Quinn NP. Clinical features and natural history of multiple system atrophy: an analysis of 100 cases. Brain 1994; 117: 835-845.
2. Kume A, Takahashi A, Hashizume Y. Neuronal cell loss of the striatonigral system in multiple system atrophy. J Neurol Sci 1993; 117: 33-40.
3. Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997; 12: 133-147.
4. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008; 71: 670-676.
5. Schocke MFH, Seppi K, Esterhammer R, et al. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology 2002; 58: 575-580.
6. Seppi K, Schocke MFH, Esterhammer R, et al. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy. Neurology 2003; 60: 922-927.
7. Nicoletti G, Lodi R, Condino F, et al. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differenziate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. Brain 2006; 129: 2679-2687.
8. Paviour DC, Thornton JS, Lees AJ, Jager HR. Diffusion-weighted magnetic resonance imaging differentiates parkinsonian variant of multiple system atrophy from progressive supranuclear palsy. Mov Disord 2007; 22: 60-74.
9. Hajnal JV, Doran M, Hall AS, et al. MR imaging of anisotropically restricted diffusion of water in the nervous system: technical, anatomic, and pathologic considerations. J Comput Assist Tomogr 1991; 15: 1-18.
10. Le Bihan D, Turner R, Douek P, Patronas N. Diffusion MR imaging: clinical applications. Am J Roentgenol 1992; 159: 359-362.
11. Pellecchia MT, Barone P, Mollica C, et al. Diffusion-weighted imaging in multiple system atrophy: A comparison between clinical subtypes. Mov Disord 2009; 24: 689-696.
12. Seppi K, Schocke MF, Mair KJ, et al. Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study. Neuroimage 2006; 31: 240-245.
13. Wenning GK, Tison F, Seppi K, et al. Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS). Mov Disord 2004; 19: 1392-1402.
14. Brenneis C, Egger K, Scherfler C, et al. Progression of brain atrophy in multiple system atrophy. A longitudinal VBM study. J Neurol 2007; 254: 191-196.
15. Kanazawa M, Shimohata T, Terajima K, et al. Quantitative evaluation of brainstem involvement in multiple system atrophy by diffusion-weighted MR imaging. J Neurol 2004; 251: 1121-1124.
16. Minnerop M, Specht K, Ruhlmann J, et al. Voxel-based morphometry and voxel-based relaxometry in multiple system atrophy-a comparison between clinical subtypes and correlations with clinical parameters. Neuroimage 2007; 15; 36: 1086-1095.
17. Tzarouchi LC, Astrakas LG, Kontsiotis S, et al. Voxel-based morphometry and voxel-based relaxometry in parkinsonian variant of multiple system atrophy. J Neuroimaging 2010; 20: 260-266.
18. Chang CC, Chang YY, Chang WN, et al. Cognitive deficits in multiple system atrophy correlate with frontal atrophy and disease duration. Eur J Neurol 2009; 16: 1144-1150.
19. Kitayama M, Wada-Isoe K, Irizawa Y, Nakashima K. Assessment of dementia in patients with multiple system atrophy. Eur J Neurol 2009; 16: 589-594.
20. Armstrong RA, Cairns NJ, Lantos PL. A quantitative study of the pathological changes in white matter in multiple system atrophy. Neuropathology 2007; 27: 221-227.
21. Lyoo CH, Yeong Y, Ryu YH, et al. Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy. Brain 2008; 131: 438-446.
22. Naganawa S, Sato K, Katagiri T, Mimura T, Ishigaki T. Regional ADC values of the normal brain: differences due to age, gender, and laterality. Eur Radiol 2003; 13: 6-11.
23. Abe O, Aoki S, Ayashi N, et al. Normal aging in the central nervous system: quantitative MR diffusion-tensor analysis. Neurobiol Aging 2002; 23: 433-441.
24. Engelter ST, Provenzale JM, Petrella JR, DeLong DM, MacFall JR. The effect of aging on the apparent diffusion coefficient of normal-appearing white matter. Am J Roentgenol 2000; 175: 425-430.
25. Molko N, Pappata S, Mangin JF, et al. Monitoring disease progression in CADASIL with diffusion magnetic resonance imaging: a study with whole brain histogram analysis. Stroke 2002; 33: 2902-2908.
26. Vandenberghe W, Demaerel P, Dom R, Maes F. Diffusion-weighted versus volumetric imaging of the striatum in early symptomatic Huntington disease. J Neurol 2009; 256: 109-114.
27. Fox NC, Cousens S, Scahill R, Harvey RJ, Rossor MN. Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects. Arch Neurol 2000; 57: 339-344.
28. Paviour DC, Price SL, Lees AJ, Fox NC. MRI derived brain atrophy in PSP and MSA-P. Determining sample size to detect treatment effects. J Neurol 2007; 254: 478-481.